DIAGNOSTIC IMAGING SERVICES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Diagnostic Imaging Services Market Size and Trends

The diagnostic imaging services market is estimated to be valued at USD 533.99 Bn in 2024 and is expected to reach USD 787.55 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.7% from 2024 to 2031.

To learn more about this report, request sample copy

The diagnostic imaging services market is expected to grow steadily over the forecast period. Key factors, such as rising geriatric population prone to chronic diseases, technological advancements in diagnostic imaging modalities, increasing investments and reimbursements for disease diagnosis, and surging demand for early disease diagnosis will contribute to the growth of this market between 2024 and 2031. Advanced technologies, such as 3D ultrasound, mobile MRI systems, and interventional imaging solutions, are enhancing disease detection capabilities. Greater acceptance of diagnostic imaging for clinical decisions is also augmenting the demand. Furthermore, supportive government initiatives for improving health services will provide impetus to the market. However, the dearth of skilled professionals and high costs associated with advanced systems may hinder the market growth to some extent.

Rising Prevalence of Chronic Diseases

As the global population is aging significantly, especially in developed countries, there is a rising prevalence of chronic and lifestyle diseases. Older individuals are more susceptible to conditions like cancer, cardiac ailments, orthopedic disorders, and neurological diseases. Diagnostic imaging tests play a pivotal role in the early and accurate diagnosis of such illnesses. They help in the proper staging of cancer, determining the severity of cardiac issues, assessing bone fractures or joint problems, and evaluating brain abnormalities. Advanced modalities like CT, MRI, ultrasound, and nuclear medicine scans provide detailed internal views of the human body that often traditional examination cannot match. This growing disease burden coupled with an increase in life expectancy is anticipated to drive greater demand for diagnostic services across hospitals, imaging centers, and physician offices worldwide.

Higher expenditures on healthcare have made diagnostic imaging increasingly affordable and accessible to broader patient groups over time. Government bodies and private insurance companies in many developed markets are inclined to reimburse the costs of recommended medical scans. This encourages more individuals to opt for such tests without worrying too much about out-of-pocket expenses. It also provides financial incentive for physicians to prescribe appropriate imaging services for suspicions or confirmation of diseases. Advanced economies continue investing heavily in their public health infrastructure and systems. While spending on novel drug development and specialty treatments rises, investments into diagnostic technologies remain integral to facilitate timely clinical decision making. Affluent patients in developing markets can also avail costly scans due to the presence of top-quality medical tourism destinations and private insurance coverage. Such expenditure and favorable norms have played a role in pushing volumes higher for major imaging modalities in both hospital and freestanding centers globally.